| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |